Content Type: International Developments
Flow Neuroscience tDCS Headset Approved in Australia, Expanding Access to Evidence-Based Depression Treatment
Flow Neuroscience’s tDCS headset for depression has received TGA approval in Australia, providing a safe, at-home, evidence-based treatment option and expanding access to non-medication mental health care.
OpenAI’s Curated Therapist Network Set to Accelerate Global Demand for Mental Health Professionals
OpenAI’s new curated network of therapists, integrated with ChatGPT, could dramatically increase global demand for mental health professionals by providing seamless, immediate access to qualified support.
OpenAI Updates ChatGPT to Improve Handling of Sensitive Mental Health Conversations
OpenAI has updated ChatGPT since August 2025 to improve its handling of sensitive mental health conversations, introducing safeguards for distress, self-harm, psychosis, and emotional reliance, with subsequent updates including GPT‑5.1 maintaining and expanding these safety measures.
FDA Clears Deep TMS™ for Adolescents With Major Depressive Disorder
The FDA has cleared BrainsWay’s Deep TMS™ system as an adjunct treatment for adolescents aged 15–21 with major depressive disorder, expanding access to a noninvasive, evidence-based therapy previously available only to adults.
Global Innovations and Strategies in Digital Mental Health: Insights from the 6th Global Ministerial Mental Health Summit, Qatar
At the 6th Global Ministerial Mental Health Summit, eMHIC’s Prof. Anil Thapliyal highlighted how strategic investment, policy, and co-creation with lived experience can harness digital innovations to transform mental health care worldwide.
Accelerating Innovation in Digital Mental Health: Insights from the MHIN Innovation Showcase, London
The Mental Health Innovation Network’s Innovation Showcase in London spotlighted groundbreaking digital mental health solutions, with eMHIC highlighting global collaboration to accelerate innovation and real-world impact.
The States Step In to Regulate AI: A Policy Vacuum Filled by Local Action in the United States
US states are leading the regulation of AI in mental health by demanding transparency and oversight, but a major policy gap remains in mandating comprehensive AI safety protocols.
“America Is in the World, the World Is in America”: APA’s Council on International Psychiatry and Global Health
The APA Council on International Psychiatry and Global Health is dedicated to forging robust global mental health solutions by integrating cultural perspectives and addressing major crises like migration. They are focused on enhancing international knowledge transfer, including establishing a resource
FDA to Review AI Mental Health Devices: Setting the Stage for Regulation
The US FDA’s Digital Health Advisory Committee (DHAC) will meet on November 6, 2025 to evaluate AI-enabled digital mental health devices (including chatbots and virtual therapists) to explore how they could bridge the mental health service access gap while assessing
FTC to Investigate AI Chatbots’ Impact on Children
The FTC is preparing to investigate leading AI firms, including OpenAI, Meta, and Character.AI, over potential mental health risks chatbots pose to children. The move comes amid growing complaints and state-level probes into unsafe or misleading AI-driven interactions.
Upcoming Events
Webinar Replays
Member Login
Our Audience
eMHIC has and audience of 12 member countries (and growing) with thousands of subscribers around the world.
Share your thoughts
Have quality news or resources to share on the eMHIC Knowledge Bank? We’d love to consider publishing them for our global community.
